tiprankstipranks
Intercede Group PLC (GB:IGP)
LSE:IGP

Intercede (IGP) AI Stock Analysis

Compare
7 Followers

Top Page

GB:IGP

Intercede

(LSE:IGP)

Select Model
Select Model
Select Model
Neutral 55 (OpenAI - 5.2)
Rating:55Neutral
Price Target:
80.00 p
▼(-36.51% Downside)
Action:ReiteratedDate:03/19/26
The score is held back primarily by very weak technicals (price well below key moving averages with negative MACD and extremely low RSI/Stoch). Financials are supportive due to strong margins and low leverage, but recent revenue decline and a sharp drop in free cash flow growth reduce confidence. Valuation is moderate based on the provided P/E, with no dividend data available.
Positive Factors
High Profitability
Very high gross margins and a healthy net margin reflect a software business with low incremental costs. This durable margin profile supports reinvestment in product and security, sustains operating leverage, and makes profitability less sensitive to moderate revenue swings over months.
Negative Factors
Revenue Decline
Material year-over-year revenue decline reduces scale and undermines the recurring base that supports long-term margins. If the top-line contraction persists, it pressures R&D and sales investment, increases per-customer cost of acquisition, and can accelerate margin compression over the coming months.
Read all positive and negative factors
Positive Factors
Negative Factors
High Profitability
Very high gross margins and a healthy net margin reflect a software business with low incremental costs. This durable margin profile supports reinvestment in product and security, sustains operating leverage, and makes profitability less sensitive to moderate revenue swings over months.
Read all positive factors

Intercede (IGP) vs. iShares MSCI United Kingdom ETF (EWC)

Intercede Business Overview & Revenue Model

Company Description
Intercede Group plc, a cybersecurity company, engages in identity, credential management, and secure mobility business to enable digital trust in the United Kingdom, rest of Europe, the United States, and internationally. The company offers MyID, ...
How the Company Makes Money
Intercede makes money primarily by selling and supporting its identity and credential management software. Key revenue streams include: (1) Software licensing/subscriptions for its MyID platform and related modules, where customers pay for the rig...

Intercede Financial Statement Overview

Summary
High profitability and operating efficiency (gross margin consistently above 96% and net margin 22.89%) and a strong balance sheet with very low leverage (debt-to-equity 0.036). Offsetting this, revenue fell 17.66% and free cash flow growth declined 67.18%, indicating meaningful growth and cash-conversion pressure.
Income Statement
72
Positive
Balance Sheet
65
Positive
Cash Flow
58
Neutral
BreakdownTTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income Statement
Total Revenue17.38M17.71M19.96M12.11M9.93M10.96M
Gross Profit16.25M17.19M19.40M11.71M9.73M10.73M
EBITDA4.78M5.17M6.11M1.06M713.00K1.91M
Net Income3.63M4.05M6.02M1.31M723.00K1.53M
Balance Sheet
Total Assets25.59M28.69M25.69M17.44M12.93M13.01M
Cash, Cash Equivalents and Short-Term Investments17.82M18.67M17.23M8.33M7.79M8.03M
Total Debt1.15M619.00K804.00K465.00K756.00K1.11M
Total Liabilities9.13M11.66M12.52M10.41M7.42M8.26M
Stockholders Equity16.46M17.03M13.18M7.03M5.51M4.75M
Cash Flow
Free Cash Flow4.33M2.30M9.27M2.79M77.00K4.14M
Operating Cash Flow4.45M2.88M9.63M2.86M110.00K4.24M
Investing Cash Flow-395.00K-856.00K-358.00K-2.08M-33.00K-95.00K
Financing Cash Flow-2.47M-529.00K-333.00K-294.00K-372.00K-791.00K

Intercede Technical Analysis

Technical Analysis Sentiment
Negative
Last Price126.00
Price Trends
50DMA
108.77
Negative
100DMA
120.02
Negative
200DMA
144.49
Negative
Market Momentum
MACD
-9.95
Positive
RSI
18.43
Positive
STOCH
20.54
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:IGP, the sentiment is Negative. The current price of 126 is above the 20-day moving average (MA) of 92.40, above the 50-day MA of 108.77, and below the 200-day MA of 144.49, indicating a bearish trend. The MACD of -9.95 indicates Positive momentum. The RSI at 18.43 is Positive, neither overbought nor oversold. The STOCH value of 20.54 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:IGP.

Intercede Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
£63.09M3.7435.56%4.16%
70
Outperform
£78.39M54.182.93%-3.95%16.87%
70
Outperform
£449.89M71.101.53%1.73%-0.18%11.49%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
55
Neutral
£46.63M20.7521.69%-19.19%-41.12%
54
Neutral
£324.83M26.547.75%2.16%
41
Neutral
£13.27M-35.35-19.77%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:IGP
Intercede
77.50
-66.00
-45.99%
GB:ACSO
accesso Technology
242.00
-225.00
-48.18%
GB:GBG
GB Group plc
193.00
-107.50
-35.77%
GB:NCC
NCC Group plc
115.00
-18.07
-13.58%
GB:SPSC
Spectra Systems
205.00
-34.59
-14.44%
GB:COIN
Coinsilium Group
2.70
-0.30
-10.00%

Intercede Corporate Events

Business Operations and StrategyFinancial Disclosures
Intercede Warns on FY26 Revenue but Reaffirms 2027 Growth Target Amid Shift to Subscriptions
Negative
Mar 17, 2026
Intercede expects continued growth in annual recurring revenue for the year to 31 March 2026 as it accelerates a strategic shift from perpetual licences to subscription-based digital identity software, which is designed to improve revenue quality ...
Private Placements and FinancingRegulatory Filings and Compliance
Intercede Issues New Shares After Employee Option Exercise, Updates Voting Rights
Neutral
Jan 15, 2026
Intercede Group has issued 200,000 new ordinary shares following the exercise of employee share options under its Enterprise Management Incentive Plan, with admission of the new shares to trading on AIM expected around 22 January 2026. The issuanc...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 19, 2026